Initializing Vogelview...
Performing medical cross-referencing...
Initializing Vogelview...
Performing medical cross-referencing...
Loading...
Also reported in: U/mL
GAD65 antibodies below 5 IU/mL are within the normal reference range. Your immune system does not appear to be attacking the insulin-producing cells in your pancreas at a clinically significant level.
Absent GAD65 antibodies means your immune system is not producing antibodies against the insulin-producing cells in your pancreas. This essentially rules out autoimmune (Type 1) diabetes as an active process.
No action needed. This is a reassuring finding.
GAD65 Antibodies: {{value}} {{unit}} — absentVery low GAD65 antibodies indicate minimal to no autoimmune attack on the insulin-producing cells. This is a healthy finding for pancreatic autoimmunity.
No action needed.
GAD65 Antibodies: {{value}} {{unit}} — very lowVery low GAD65 antibodies essentially rule out active autoimmune pancreatic attack. This is a reassuring finding.
No action needed.
GAD65 Antibodies: {{value}} {{unit}} — very lowGAD65 antibodies below 5 IU/mL are within the normal reference range. Your immune system does not appear to be attacking the insulin-producing cells in your pancreas at a clinically significant level.
No action needed. This is a reassuring result if you were being screened for autoimmune diabetes.
GAD65 Antibodies: {{value}} {{unit}} — within reference range (<5 IU/mL)Optimal (undetectable or minimal) GAD65 antibodies provide strong evidence against ongoing autoimmune destruction of beta cells.
No action needed. Excellent result.
GAD65 Antibodies: {{value}} {{unit}} — optimalBorderline elevated GAD65 antibodies may represent early autoimmune activity against beta cells — before significant destruction has occurred. This is an early finding in the pre-diabetes phase of Type 1 disease (Type 1 diabetes has an autoimmune onset years before clinical presentation).
Discuss with your doctor. Monitoring fasting glucose, C-peptide, and other islet cell antibodies (IA-2, ZnT8) over time can help assess progression risk.
GAD65 Antibodies: {{value}} {{unit}} — borderline elevated (5–20 IU/mL)Elevated GAD65 antibodies is consistent with autoimmune destruction of pancreatic beta cells — the hallmark of Type 1 diabetes or LADA (latent autoimmune diabetes in adults). At this level, significant beta cell damage may already be occurring even if blood sugar appears normal. LADA can be misdiagnosed as Type 2 diabetes in adults.
See your doctor urgently for C-peptide measurement, full islet cell antibody panel, and diabetes specialist referral. Protecting remaining beta cells and planning insulin therapy (likely needed in LADA) are the priorities.
GAD65 Antibodies: {{value}} {{unit}} — above reference range (>20 IU/mL)Very high GAD65 antibodies indicate a highly active autoimmune process destroying the insulin-producing cells. Beta cell mass is likely noticeably reduced. This is the typical finding in newly diagnosed Type 1 diabetes or rapidly progressing LADA.
Seek urgent endocrinology evaluation and diabetes specialist care. Insulin therapy is likely needed. Enrollment in clinical trials for beta cell preservation may be an option.
GAD65 Antibodies: {{value}} {{unit}} — very high (>100 IU/mL)Upload your lab report and get your actual values interpreted in plain English — instantly, with no medical training required.